Drug Database
ES

estradiol (Estreva oral / Estreva / Estreva gel)

✓ Approved

Merck KGaA · ESR1 · 小分子

什么是 estradiol?

estradiol 是一种小分子,由Merck KGaA研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)、Transdermal。

药物档案

商品名Estreva oral, Estreva, Estreva gel
公司Merck KGaA
药物类别小分子
分子靶点ESR1
给药途径Oral (PO), Transdermal
状态Approved

作用机制

分子靶点

estradiol 作用于 1 个分子靶点:

ESR1estrogen receptor 1 (ER, ESR)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

estradiol 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Surgical and medical proceduresHormone replacement therapy✓ Approved

相关研究文献

PubMedBiology of sex differences2026-11-19

Mapping the sex-dimorphic hormonal ecosystem in osteoarthritis: non-linear interactions between androgen activity and estrogen.

Deng Bin B, Chen Ting T, Chen Qiao Q, Huang Liangzhi L et al.

The pronounced sex disparity in osteoarthritis (OA) risk implicates sex hormones, yet single-hormone studies have yielded inconsistent results. We hypothesized that androgen activity influences OA not in isolation but within a dynamic network defined by sex, menopausal status, and estradiol. We analyzed 13,848 adults from NHANES (2013-2016, 2021-2023) using an integrated framework combining complex-survey regression, two-way restricted cubic splines, generalized additive models (GAMs), and SHAP-based machine learning to model non-linear interactions across the estradiol-FAI plane. Higher free androgen index (FAI) was significantly associated with lower OA risk only in post-menopausal females (OR = 0.85, 95% CI: 0.74-0.97, P = 0.021); associations in pre-menopausal females (OR = 0.75, P = 0.145) and males (OR = 0.94, P = 0.714) were not statistically significant. Non-linear models revealed distinct regional patterns: a "buffering" pattern in post-menopausal females, where the low-estradiol/low-FAI quadrant exhibited the highest risk (GAM P = 0.002; regional synergy mean = 0.077); a "cross-over" pattern in males (GAM P = 0.042); and a flat surface in pre-menopausal females, serving as a negative control. Candidate boundaries (e.g., estradiol ≈ 2.63, FAI ≈ - 0.54 in post-menopausal females) emerged from SHAP dependence plots as hypothesis-generating indicators requiring formal validation. Machine learning confirmed that standalone predictive contributions of sex hormones were minimal (mean |SHAP| ≤ 0.0135), supporting their role as contextual modulators rather than primary drivers. Sex hormone effects on OA are context-dependent and non-linear, only discernible when examined in combination. The regional risk patterns-particularly the low-low quadrant in post-menopausal females-represent the robust core of our findings and provide a conceptual framework for understanding sex disparities through steroid interaction. Candidate boundaries are hypothesis-generating and await validation.

PMID 43053217
阅读全文 →
PubMedClinical oral investigations2026-11-19

Intra-sulcular compound chamomile and lidocaine hydrochloride gel for procedural pain during ultrasonic scaling: a randomized, single-blind, split-mouth, sham-controlled superiority trial in adults with plaque-induced gingivitis.

Tang Rong R, Yin Tingting T, Liang Jia J, Wang Ruijie R et al.

This study aimed to evaluate whether intra-sulcular application of a compound chamomile and lidocaine hydrochloride gel (Kami-Gel) reduces procedural pain during ultrasonic supragingival scaling in adults with plaque-induced gingivitis compared with a sham procedure. A single-center, randomized, single-blind, split-mouth, sham-controlled superiority trial was conducted involving 114 adults with plaque-induced gingivitis. Participants received a sequential split-mouth treatment. The test side received intra-sulcular application of Kami-Gel, while the control side received a sham application (mimicked injection). The primary outcome was procedural pain intensity measured on a 0-10 Visual Analog Scale (VAS). Secondary outcomes included the number of pain complaints, procedural duration, patient satisfaction, and plaque index (PI). Safety was assessed immediately and at 24 h. All 114 participants completed the study. Median VAS score was significantly lower in the test group (1.7 [IQR: 0.62-2.58]) than the control group (4.1 [IQR: 2.42-5.7]), with an estimated treatment difference of - 2.35 (95% CI: -3.0 to - 1.7)-the upper limit of which fell below the pre-specified superiority margin of - 1.2, confirming superiority (P < 0.001). The test group also demonstrated significantly fewer pain complaints (median 0 vs. 1), shorter procedural duration (median 10 vs. 12 min), and higher patient satisfaction (all P < 0.001). Post-scaling plaque index was significantly lower in the test group (median 0.75 [IQR: 0.55-0.86] vs. 0.89 [IQR: 0.75-0.96]; P < 0.001), though this difference may reflect improved patient cooperation rather than a direct pharmacological effect. No adverse events were reported. Intra-sulcular application of compound chamomile and lidocaine hydrochloride gel reduces procedural pain during ultrasonic supragingival scaling compared to a sham procedure. Its use was associated with shorter active scaling time and higher satisfaction. Whether these acute benefits translate to improved long-term periodontal treatment compliance warrants further investigation. Intra-sulcular application of compound chamomile and lidocaine gel (Kami-Gel) prior to ultrasonic supragingival scaling reduces procedural pain and was associated with higher patient satisfaction. A lower post-scaling plaque index was observed in the test group, potentially attributable to improved patient cooperation during instrumentation. This safe, non-injectable chairside technique provides clinicians a practical tool to enhance patient comfort during scaling procedures.

PMID 43052462
阅读全文 →
PubMedJournal of the American Chemical Society2026-11-19

Ultrastretchable, Tissue-Matched Piezoelectric Gel with Preferentially Oriented Molecular Ferroelectric Crystallization.

Chen Hao-Ran HR, Zhang Yu-Hao YH, Ding Lei L, Li Jun-Yi JY et al.

Molecular ferroelectrics hold great potential for bioelectronics because of their excellent piezoelectric responses and biocompatibility. However, conventional integration into gel matrices suffers from two major drawbacks: solvent evaporation methods often yield brittle films with poor modulus matching with soft tissues, whereas physical blending typically leads to filler agglomeration and random crystal dispersion, making it difficult to achieve preferential crystal orientation and thereby limiting the piezoelectric performance. Here, we report an in situ crystallization strategy assisted by solvent exchange. This approach enables preferentially oriented triglycine sulfate (TGS) crystals to form within a polyacrylamide (PAM) network reinforced by glycidyl methacrylate-grafted bovine serum albumin (B-G). The B-G macromer strengthens the network through covalent integration and reversible hydrogen-bonding interactions. Subsequent treatment with a choline chloride/sorbitol deep eutectic solvent (DES) induced the preferential orientation of TGS within the gel matrix. The resulting gel achieved a fracture strain exceeding 2800%, maintained mechanical integrity over 10000 loading-unloading cycles, and exhibited mechanical compliance within the range of human soft tissues (10-5-10-4 Pa-1). In vitro and in vivo evaluations further demonstrated favorable biocompatibility and its potential for flexible piezoelectric sensing applications. This work provides molecular-level insight into the design of highly conformable piezoelectric gels containing preferentially oriented molecular ferroelectrics for tissue-matched biointerfaces.

PMID 43053447
阅读全文 →
PubMedJournal of ovarian research2026-11-19

Effect of estradiol decrease from the hCG trigger day to the embryo transfer day on clinical outcomes in diminished ovarian reserve patients undergoing GnRH-antagonist protocol: a retrospective study.

Yuan Yangxuan Y, Xu Mingyang M, Meng Yicen Y, Ming Lei L et al.

Diminished ovarian reserve (DOR) represents a critical clinical challenge in assisted reproductive technology (ART), and the gonadotropin-releasing hormone (GnRH) antagonist protocol has become a commonly used regimen for DOR treatment. Although estradiol (E₂) is well established as a pivotal regulator of embryo implantation, the prognostic impact of E₂ decrease from the human chorionic gonadotropin (hCG) trigger day to the embryo transfer day on ART outcomes remains unclear in DOR patients undergoing a GnRH-antagonist protocol. This retrospective study included 570 eligible in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles of DOR patients classified as POSEIDON Groups 3 and 4, who received the GnRH-antagonist protocol at Renmin Hospital of Wuhan University between July 2019 and September 2024. The optimal cut-off value for E₂ decrease was determined using receiver operating characteristic (ROC) curve analysis. Cycles were stratified into two groups based on the cut-off: Group A (E₂ decrease < 51%) and Group B (E₂ decrease ≥ 51%). Reproductive outcomes were compared between the two groups, and multivariable binary logistic regression analysis was performed to evaluate factors associated with clinical pregnancy. Compared with the patients in non-pregnant group, the pregnant group had lower maternal age, P levels on the hCG trigger day and duration of antagonist, but had higher BMI, AFC and the proportion of patients with E₂ decrease < 51%. The logistic regression analysis indicated that the E₂ decrease group was independently associated with clinical pregnancy after multivariable adjustment. Based on the ROC-derived cut-off value, Group A had significantly higher clinical pregnancy rates [47.4% (54/114) versus 26.8% (33/123) (P < 0.01)] and embryo implantation rates [33.0% (60/182) versus 20.0% (39/195) (P < 0.01)] compared with Group B. DOR patients with an E₂ decrease of less than 51% from the hCG trigger day to the embryo transfer day showed relatively better clinical outcomes under a GnRH-antagonist protocol. Monitoring peri-transfer E₂ changes may provide complementary prognostic information.

PMID 43053039
阅读全文 →
PubMedBMC infectious diseases2026-11-19

CT-detected gynecomastia in men living with HIV: prevalence, radiological patterns, and associated factors.

Akca Veysel V, Sarı Ferda Bacaksızlar FB, Togan Turhan T

To determine the prevalence of CT-detected gynecomastia in men living with HIV, characterize its radiological subtypes, and investigate potential associations with hormonal, clinical, virological, and treatment-related factors. This retrospective observational study included 170 adult men living with HIV who underwent thoracic computed tomography (CT) examinations performed on a Somatom Definition Flash multidetector CT scanner (Siemens Healthineers, Forchheim, Germany) between January 2023 and January 2025. CT examinations were reviewed for the presence of gynecomastia, laterality, and radiological subtype (nodular, dendritic, or diffuse). Demographic characteristics, duration of HIV infection, antiretroviral treatment (ART) regimens, hormonal parameters, body mass index (BMI), CD4 and CD8 counts, CD4/CD8 ratio, HIV RNA levels, and CDC stage were obtained from medical records. Multivariable logistic regression analyses were performed to identify factors associated with gynecomastia and its radiological subtypes. The mean age of the study population was 39.7 ± 11.8 years. Gynecomastia was identified in 60 patients (35.3%), with bilateral involvement in 86.7% of cases. Bilateral disease was present in 68.2% of nodular, 84.2% of dendritic, and 95.2% of diffuse gynecomastia cases. The prevalence of gynecomastia did not differ significantly among ART regimens (p = 0.743). Estradiol levels, testosterone levels, estradiol-to-testosterone ratio, BMI, CD4 count, CD8 count, CD4/CD8 ratio, and HIV RNA levels were not independently associated with gynecomastia. In multivariable analyses, use of DTG/3TC was associated with lower odds of gynecomastia (OR: 0.115, p = 0.033). For diffuse gynecomastia, longer duration of HIV infection was independently associated with increased odds (OR: 1.419, p = 0.005). No independent predictors were identified for nodular or dendritic gynecomastia. Gynecomastia is a common incidental finding on thoracic CT in men living with HIV, affecting more than one-third of patients in this cohort. Despite the relatively young age of the study population, the prevalence was comparable to that reported in large CT-based studies from the general Turkish population. HIV duration, rather than hormonal, immunological, or virological parameters, was associated with diffuse gynecomastia, suggesting that breast tissue changes may reflect cumulative long-term effects of HIV infection and its treatment. Not applicable.

PMID 43052786
阅读全文 →
PubMedJournal of the American Chemical Society2026-11-19

Intermediate Phase Selectivity in ZSM-5 Zeolite Synthesis and Framework Aluminum Distribution.

Zeng Jinjin J, Zheng Mingji M, Tan Xuechao X, Xu Jun J et al.

The current understanding of zeolite crystallization is still far from well understood. Herein, we show that the crystallization pathway of high-silica ZSM-5, one of the most industrially important zeolites, can be altered not only by the type of organic structure-directing agents (OSDAs) at a gel Si/Al ratio of 50 but also by the simultaneous use of Na+ and Cs+ ions as inorganic structure-directing agents (ISDAs). The use of the diquaternary OSDA 1,8-bis(N-methylpyrrolidinium)octane (1,8-MPO) instead of tetrapropylammonium (TPA), the most common OSDA for the synthesis of ZSM-5, in the presence of Na+ led to zeolite β as an intermediate phase; otherwise, no crystalline intermediate was observed. Also, the addition of a small amount of Cs+ ions (gel Cs/Na = 0.14) as a secondary ISDA to the 1,8-MPO-Na+ and TPA-Na+ systems gave small-pore zeolites bikitaite and analcime as an intermediate phase during synthesis, respectively. More importantly, we found that the framework Al distribution in the final product ZSM-5 could differ according to the in situ transformation pathway of intermediate phases, as well as to the type of OSDA used. This study provides a new strategy for directly controlling the intrazeolitic location of Brønsted acid sites, as well as the nucleation pathway in the synthesis of high-silica zeolites.

PMID 43053369
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多estradiol